Department of Pathology ~ Genomic Tumor Board

EVENT DETAILS AND REGISTRATION

Date:May 19, 2017

Time: 09:00 AM - 10:00 AM (PT)

Location:CP Conference Room 2287A

Event Is:

  • Discuss molecular  pathways of solid tumors (Glioma, melanoma, Colon, lung, thyroid, etc.) and hematologic malignancy
  • Integrate molecular findings with morphology and clinical information
  • Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected
  • Consensus conference of calling the alterations in respect to a disease and ethnicity of the patient
  • Identify available clinical trials for the specific alterations

Presenters:Michelle Afkhami, MD Milhan Telatar, MD

ADDITIONAL DETAILS:

Objectives:

  • Discuss molecular  pathways of solid tumors (Glioma, melanoma, Colon, lung, thyroid, etc.) and hematologic malignancy
  • Integrate molecular findings with morphology and clinical information
  • Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected
  • Consensus conference of calling the alterations in respect to a disease and ethnicity of the patient
  • Identify available clinical trials for the specific alterations

Who should attend:

Pathologists, solid tumor oncologists, hematology oncologists, hematopathologists, hematologists, and endocrinology fellows, surgery, neurosurgeons, dermatologists,  head and neck surgeons, Beckman research scientists

CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: Please contact Brenda Phifer Ext. 84401

Contact:

Brenda Phifer